|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||||
| Cash and due from banks | |||||||||||||||
| Interest-earning bank balances | |||||||||||||||
| Due from Federal Reserve Bank | |||||||||||||||
| Total cash and cash equivalents | |||||||||||||||
| Securities available-for-sale, at fair value (amortized cost $268,978 and $189,924 at June 30, 2026 and December 31, 2025, respectively) | |||||||||||||||
| Securities held-to-maturity (fair value $150 and $154 at June 30, 2026 and December 31, 2025, respectively) | |||||||||||||||
| Loans receivable, net of deferred fees and costs | |||||||||||||||
| Less: allowance for credit losses for loans | |||||||||||||||
| Loan receivable, net | |||||||||||||||
| Bank-owned life insurance | |||||||||||||||
| Premises and equipment, net | |||||||||||||||
| Accrued interest receivable | |||||||||||||||
| Restricted investment in bank stock | |||||||||||||||
| Deferred taxes, net | |||||||||||||||
| Goodwill | |||||||||||||||
| Core deposit intangible | |||||||||||||||
| Mortgage servicing rights | |||||||||||||||
| Other real estate owned | |||||||||||||||
| Operating lease right-of-use asset | |||||||||||||||
| Equity method investments | |||||||||||||||
| Other assets | |||||||||||||||
| TOTAL ASSETS | |||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||||||||||
| LIABILITIES | |||||||||||||||
| Deposits: | |||||||||||||||
| Non-interest-bearing | |||||||||||||||
| Interest-bearing | |||||||||||||||
| Total deposits | |||||||||||||||
| Borrowings | |||||||||||||||
| Accrued interest payable | |||||||||||||||
| Operating lease liability | |||||||||||||||
| Other liabilities | |||||||||||||||
| TOTAL LIABILITIES | |||||||||||||||
| STOCKHOLDERS' EQUITY: | |||||||||||||||
| Preferred stock, no par value; 2,000,000 shares authorized and none outstanding at June 30, 2026 and at December 31, 2025 | |||||||||||||||
| Common stock, no par value; 15,000,000 shares authorized, 7,099,127 shares issued and 6,813,201 outstanding at June 30, 2026; 7,042,206 shares issued and 6,765,530 outstanding at December 31, 2025 | |||||||||||||||
| Paid-in capital | |||||||||||||||
| Treasury stock, at cost; 285,926 shares at June 30, 2026 and 276,676 shares at December 31, 2025 | |||||||||||||||
| Retained earnings | |||||||||||||||
| Accumulated other comprehensive loss | |||||||||||||||
| TOTAL STOCKHOLDERS' EQUITY | |||||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY |
Loading...
